Comment: This systematic review and meta-analysis is yet another high-level confirmation of a reality seen across decades of human clinical data: soy isoflavones do not possess the systemic estrogenic risks often attributed to them. In the hierarchy of research, human RCTs carry the most weight, and the aggregation of 42 randomized controlled trials here should […]

Read More »